114 related articles for article (PubMed ID: 38603533)
1. Trends in low-value cancer care during the COVID-19 pandemic.
Parikh RB; Civelek Y; Ozluk P; Debono D; Fisch MJ; Sylwestrzak G; Bekelman JE; Schwartz AL
Am J Manag Care; 2024 Apr; 30(4):186-190. PubMed ID: 38603533
[TBL] [Abstract][Full Text] [Related]
2. Trends in US Ambulatory Care Patterns During the COVID-19 Pandemic, 2019-2021.
Mafi JN; Craff M; Vangala S; Pu T; Skinner D; Tabatabai-Yazdi C; Nelson A; Reid R; Agniel D; Tseng CH; Sarkisian C; Damberg CL; Kahn KL
JAMA; 2022 Jan; 327(3):237-247. PubMed ID: 35040886
[TBL] [Abstract][Full Text] [Related]
3. Association of Cancer Screening Deficit in the United States With the COVID-19 Pandemic.
Chen RC; Haynes K; Du S; Barron J; Katz AJ
JAMA Oncol; 2021 Jun; 7(6):878-884. PubMed ID: 33914015
[TBL] [Abstract][Full Text] [Related]
4. Association of Utilization Management Policy With Uptake of Hypofractionated Radiotherapy Among Patients With Early-Stage Breast Cancer.
Parikh RB; Fishman E; Chi W; Zimmerman RP; Gupta A; Barron JJ; Sylwestrzak G; Bekelman JE
JAMA Oncol; 2020 Jun; 6(6):839-846. PubMed ID: 32297905
[TBL] [Abstract][Full Text] [Related]
5. Breast and Lung Cancer Screening Among Medicare Enrollees During the COVID-19 Pandemic.
Doan C; Li S; Goodwin JS
JAMA Netw Open; 2023 Feb; 6(2):e2255589. PubMed ID: 36735262
[TBL] [Abstract][Full Text] [Related]
6. Cancer Screening Disparities Before and After the COVID-19 Pandemic.
Lofters AK; Wu F; Frymire E; Kiran T; Vahabi M; Green ME; Glazier RH
JAMA Netw Open; 2023 Nov; 6(11):e2343796. PubMed ID: 37983033
[TBL] [Abstract][Full Text] [Related]
7. Trends in Methadone Dispensing for Opioid Use Disorder After Medicare Payment Policy Changes.
Taylor EA; Cantor JH; Bradford AC; Simon K; Stein BD
JAMA Netw Open; 2023 May; 6(5):e2314328. PubMed ID: 37204793
[TBL] [Abstract][Full Text] [Related]
8. High-Acuity Alcohol-Related Complications During the COVID-19 Pandemic.
Shuey B; Halbisen A; Lakoma M; Zhang F; Argetsinger S; Williams EC; Druss BG; Wen H; Wharam JF
JAMA Health Forum; 2024 Apr; 5(4):e240501. PubMed ID: 38607643
[TBL] [Abstract][Full Text] [Related]
9. Long-term health care costs following COVID-19: implications for pandemic preparedness.
Chambers LC; Park A; Cole M; Lovgren L; Zandstra T; Beaudoin FL; Collins M
Am J Manag Care; 2023 Nov; 29(11):566-572. PubMed ID: 37948643
[TBL] [Abstract][Full Text] [Related]
10. Economic burden in direct costs of concomitant chronic obstructive pulmonary disease and asthma in a Medicare Advantage population.
Blanchette CM; Gutierrez B; Ory C; Chang E; Akazawa M
J Manag Care Pharm; 2008 Mar; 14(2):176-85. PubMed ID: 18331119
[TBL] [Abstract][Full Text] [Related]
11. Uptake and costs of hypofractionated vs conventional whole breast irradiation after breast conserving surgery in the United States, 2008-2013.
Bekelman JE; Sylwestrzak G; Barron J; Liu J; Epstein AJ; Freedman G; Malin J; Emanuel EJ
JAMA; 2014 Dec; 312(23):2542-50. PubMed ID: 25494006
[TBL] [Abstract][Full Text] [Related]
12. Changes in cancer diagnoses and stage distribution during the first year of the COVID-19 pandemic in the USA: a cross-sectional nationwide assessment.
Han X; Yang NN; Nogueira L; Jiang C; Wagle NS; Zhao J; Shi KS; Fan Q; Schafer E; Yabroff KR; Jemal A
Lancet Oncol; 2023 Aug; 24(8):855-867. PubMed ID: 37541271
[TBL] [Abstract][Full Text] [Related]
13. Telemedicine Use and Quality of Opioid Use Disorder Treatment in the US During the COVID-19 Pandemic.
Hailu R; Mehrotra A; Huskamp HA; Busch AB; Barnett ML
JAMA Netw Open; 2023 Jan; 6(1):e2252381. PubMed ID: 36692880
[TBL] [Abstract][Full Text] [Related]
14. Heterogeneous impact of the COVID-19 pandemic on lung, colorectal and breast cancer incidence in Hungary: results from time series and panel data models.
Elek P; Csanádi M; Fadgyas-Freyler P; Gervai N; Oross-Bécsi R; Szécsényi-Nagy B; Tatár M; Váradi B; Zemplényi A
BMJ Open; 2022 Aug; 12(8):e061941. PubMed ID: 35981776
[TBL] [Abstract][Full Text] [Related]
15. Outcomes for Out-of-Hospital Cardiac Arrest in the United States During the Coronavirus Disease 2019 Pandemic.
Chan PS; Girotra S; Tang Y; Al-Araji R; Nallamothu BK; McNally B
JAMA Cardiol; 2021 Mar; 6(3):296-303. PubMed ID: 33188678
[TBL] [Abstract][Full Text] [Related]
16. Breast cancer diagnosis and treatment during the COVID-19 pandemic in a nationwide, insured population.
Caswell-Jin JL; Shafaee MN; Xiao L; Liu M; John EM; Bondy ML; Kurian AW
Breast Cancer Res Treat; 2022 Jul; 194(2):475-482. PubMed ID: 35624175
[TBL] [Abstract][Full Text] [Related]
17. Racial and Ethnic Disparities in Buprenorphine and Extended-Release Naltrexone Filled Prescriptions During the COVID-19 Pandemic.
Nguyen T; Ziedan E; Simon K; Miles J; Crystal S; Samples H; Gupta S
JAMA Netw Open; 2022 Jun; 5(6):e2214765. PubMed ID: 35648400
[TBL] [Abstract][Full Text] [Related]
18. Comparison of Out-of-Pocket Spending on Ultra-Expensive Drugs in Medicare Part D vs Commercial Insurance.
DiStefano MJ; Kang SY; Parasrampuria S; Anderson GF
JAMA Health Forum; 2023 May; 4(5):e231090. PubMed ID: 37234016
[TBL] [Abstract][Full Text] [Related]
19. Association Between the COVID-19 Pandemic and Insurance-Based Disparities in Mortality After Major Surgery Among US Adults.
Glance LG; Dick AW; Shippey E; McCormick PJ; Dutton R; Stone PW; Shang J; Lustik SJ; Lander HL; Gosev I; Joynt Maddox KE
JAMA Netw Open; 2022 Jul; 5(7):e2222360. PubMed ID: 35849395
[TBL] [Abstract][Full Text] [Related]
20. Health Plan Enrollment and Disenrollment of Individuals With and Without Established Chronic Disease in a U.S. Commercially Insured and Medicare Advantage Population.
Chung H; Deshpande G; Zolotarjova J; Quimbo RA; Kern DM; Cochetti PT; Willey VJ
J Manag Care Spec Pharm; 2019 May; 25(5):612-620. PubMed ID: 31039058
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
